NCT02903914 2025-08-05Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsIncyte CorporationPhase 1 Completed260 enrolled 52 charts